$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

$uavs Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040239 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$2.922M	$3.484M	$5.491M
YoY Change	-34.68%	-36.55%	171.59%
Cost Of Revenue	$1.683M	$2.270M	$3.408M
YoY Change	-25.32%	-33.39%	177.74%
Gross Profit	$1.239M	$1.214M	$2.083M
YoY Change	-44.19%	-41.72%	162.1%
Gross Profit Margin	42.4%	34.85%	37.94%
Selling, General & Admin	$3.987M	$4.336M	$5.412M
YoY Change	-17.32%	-19.88%	41.77%
% of Gross Profit	321.76%	357.13%	259.8%
Research & Development	$1.203M	$1.368M	$1.819M
YoY Change	-37.59%	-24.75%	134.03%
% of Gross Profit	97.12%	112.71%	87.3%
Depreciation & Amortization	$781.8K	$93.61K	$110.2K
YoY Change	-25.66%	-15.03%	-66.6%
% of Gross Profit	63.1%	7.71%	5.29%
Operating Expenses	$5.190M	$7.204M	$7.230M
YoY Change	-23.58%	-0.36%	57.38%
Operating Profit	-$3.951M	-$5.990M	-$5.147M
YoY Change	-13.57%	16.37%	35.47%
Interest Expense	$46.19K	$84.44K	-$6.730K
YoY Change	-253.92%	-1354.73%	-275.72%
% of Operating Profit
Other Income/Expense, Net	-$21.16K	-$2.030M	$6.812M
YoY Change	-94.46%	-129.8%	27368.88%
Pretax Income	-$24.51M	-$8.020M	$1.665M
YoY Change	-47.54%	-581.7%	-144.15%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$24.51M	-$8.020M	$1.665M
YoY Change	-47.54%	-581.7%	-144.15%
Net Earnings / Revenue	-838.81%	-230.2%	30.32%
Basic Earnings Per Share		-$0.07	$0.02
Diluted Earnings Per Share	-$3.91	-$0.07	$0.01
COMMON SHARES
Basic Shares Outstanding	117.9M shares	109.5M shares	87.00M shares
Diluted Shares Outstanding		111.1M shares	113.6M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$819.0K	$1.600M	$5.302M
YoY Change	-81.17%	-69.83%	-83.54%
Cash & Equivalents	$819.0K	$1.600M	$5.302M
Short-Term Investments
Other Short-Term Assets	$548.6K	$800.0K	$1.210M
YoY Change	-46.72%	-33.86%	20.8%
Inventory	$6.937M	$6.064M	$6.118M
Prepaid Expenses		$832.2K	$1.210M
Receivables	$2.058M	$2.015M	$3.178M
Other Receivables	$185.0K	$200.0K	$185.0K
Total Short-Term Assets	$10.55M	$10.70M	$15.99M
YoY Change	-27.08%	-33.12%	-55.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$799.9K	$598.0K	$838.1K
YoY Change	1.1%	-28.65%	-39.85%
Goodwill	$7.403M	$21.68M	$64.87M
YoY Change	-68.06%	-66.58%
Intangibles	$2.615M	$9.243M	$12.22M
YoY Change	-77.27%	-24.35%
Long-Term Investments
YoY Change
Other Assets	$265.6K	$300.0K	$279.8K
YoY Change	-8.76%	7.21%	1019.28%
Total Long-Term Assets	$14.61M	$35.35M	$79.35M
YoY Change	-63.22%	-55.45%	9.75%
TOTAL ASSETS
Total Short-Term Assets	$10.55M	$10.70M	$15.99M
Total Long-Term Assets	$14.61M	$35.35M	$79.35M
Total Assets	$25.16M	$46.05M	$95.34M
YoY Change	-53.57%	-51.7%	-12.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.063M	$2.126M	$2.194M
YoY Change	65.99%	-3.12%	84.88%
Accrued Expenses	$1.944M	$2.500M	$215.9K
YoY Change	448.87%	1057.88%	-82.88%
Deferred Revenue	$226.3K	$329.5K	$653.2K
YoY Change	-54.41%	-49.55%
Short-Term Debt	$4.505M	$2.600M	$0.00
YoY Change	1467.44%
Long-Term Debt Due	$391.6K	$300.0K	$380.3K
YoY Change	-12.3%	-21.12%
Total Short-Term Liabilities	$11.03M	$7.878M	$5.772M
YoY Change	104.89%	36.5%	-18.29%
LONG-TERM LIABILITIES
Long-Term Debt	$489.0K	$509.2K	$634.3K
YoY Change	9.45%	-19.72%
Other Long-Term Liabilities	$2.938M	$2.800M	$660.3K
YoY Change	-10.1%	324.08%	-91.07%
Total Long-Term Liabilities	$489.0K	$509.2K	$634.3K
YoY Change	9.45%	-19.72%	-91.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.03M	$7.878M	$5.772M
Total Long-Term Liabilities	$489.0K	$509.2K	$634.3K
Total Liabilities	$14.46M	$12.61M	$7.066M
YoY Change	31.91%	78.51%	-51.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$165.6M	-$134.4M	-$62.59M
YoY Change	48.43%	114.7%
Common Stock	$140.5K	$117.9K	$87.45K
YoY Change	58.84%	34.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.70M	$33.44M	$88.28M
YoY Change
Total Liabilities & Shareholders Equity	$25.16M	$46.05M	$95.34M
YoY Change	-53.57%	-51.7%	-12.23%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$24.51M	-$8.020M	$1.665M
YoY Change	-47.54%	-581.7%	-144.15%
Depreciation, Depletion And Amortization	$781.8K	$93.61K	$110.2K
YoY Change	-25.66%	-15.03%	-66.6%
Cash From Operating Activities	-$2.126M	-$2.050M	-$3.714M
YoY Change	-55.38%	-44.8%	17.1%
INVESTING ACTIVITIES
Capital Expenditures	$115.4K	$50.00K	-$113.2K
YoY Change	81.98%	-144.16%	651.86%
Acquisitions
YoY Change
Other Investing Activities	-$91.61K	-$90.00K	-$3.945M
YoY Change	-60.79%	-97.72%	-34.95%
Cash From Investing Activities	-$217.0K	-$140.0K	-$4.059M
YoY Change	-26.95%	-96.55%	-33.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.821M	-50.00K	12.85K
YoY Change	-44.58%	-489.11%	-99.43%
NET CHANGE
Cash From Operating Activities	-2.126M	-2.050M	-3.714M
Cash From Investing Activities	-217.0K	-140.0K	-4.059M
Cash From Financing Activities	1.821M	-50.00K	12.85K
Net Change In Cash	-522.8K	-2.240M	-7.760M
YoY Change	-70.59%	-71.13%	10.96%
FREE CASH FLOW
Cash From Operating Activities	-$2.126M	-$2.050M	-$3.714M
Capital Expenditures	$115.4K	$50.00K	-$113.2K
Free Cash Flow	-$2.242M	-$2.100M	-$3.601M
YoY Change	-53.58%	-41.68%	14.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000008504
CY2023Q3	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock		usd
CY2022Q3	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock		usd
	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2015045	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6063935	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
	UAVS	Payment Of Acquisitionrelated Liabilities PaymentOfAcquisitionrelatedLiabilities		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	UAVS	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant		usd
	UAVS	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition		usd
	UAVS	Settlement Of Common Stock From Contingent Liability Related To Measure SettlementOfCommonStockFromContingentLiabilityRelatedToMeasure		usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36492
	dei	Entity Registrant Name EntityRegistrantName	AGEAGLE AERIAL SYSTEMS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0422242
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8201 E. 34th
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wichita
	dei	Entity Address State Or Province EntityAddressStateOrProvince	KS
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	67226
	dei	City Area Code CityAreaCode	(620)
	dei	Local Phone Number LocalPhoneNumber	325-6363
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	UAVS
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	117878831	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1600143	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4349837	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	832188	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1029548	usd
CY2023Q3	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	185000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	10696311	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14463272	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	597964	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3498051	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9242659	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11507653	usd
CY2023Q3	us-gaap	Goodwill Goodwill	21679411	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	336091	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	291066	usd
CY2023Q3	us-gaap	Assets Assets	46050487	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2125689	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1845135	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1650609	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1680706	usd
CY2023Q3	UAVS	Promissory Note PromissoryNote	2625000	usd
CY2022Q4	UAVS	Promissory Note PromissoryNote	287381	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	329536	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	496390	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	840535	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q3	UAVS	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	306722	usd
CY2022Q4	UAVS	Current Portion Of Covid Loan CurrentPortionOfCovidLoan	446456	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	7878091	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5384181	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2756056	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	509184	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	446813	usd
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	106163	usd
CY2023Q3	UAVS	Long Term Portion Of Promissory Note LongTermPortionOfPromissoryNote	1470000	usd
CY2022Q4	UAVS	Long Term Portion Of Promissory Note LongTermPortionOfPromissoryNote	1861539	usd
CY2023Q3	us-gaap	Liabilities Liabilities	12613331	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10960399	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	6	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117878831	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117878831	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88466613	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	88466613	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	117880	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	88467	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167523676	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154679363	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134374548	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-111553444	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	170142	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	10083	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	33437156	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46050487	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54184874	usd
CY2023Q3	us-gaap	Revenues Revenues	3483932	usd
CY2022Q3	us-gaap	Revenues Revenues	5490714	usd
	us-gaap	Revenues Revenues	10819213	usd
	us-gaap	Revenues Revenues	14620565	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2269858	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3407573	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6594973	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8622436	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1214074	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	2083141	usd
	us-gaap	Gross Profit GrossProfit	4224240	usd
	us-gaap	Gross Profit GrossProfit	5998129	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3357550	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4175090	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10435834	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14093655	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1368394	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1818540	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4320216	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6185777	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	978243	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1236841	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2911963	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3736548	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1500000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1579287	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7204187	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	7230471	usd
	us-gaap	Operating Expenses OperatingExpenses	19247300	usd
	us-gaap	Operating Expenses OperatingExpenses	24015980	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5990113	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5147330	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15023060	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18017851	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-399651	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6727	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-994751	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-29776	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1523867	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6486899	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1523867	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6486899	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-106497	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	332110	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-368532	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	27372	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2030015	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6812282	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2887150	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6484495	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8020128	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1664952	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17910210	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11533356	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8020128	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1664952	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17910210	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11533356	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	111083155	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85966687	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98976085	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81004011	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111083155	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	113623789	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98976085	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81004011	shares
CY2023Q3	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-8020128	usd
CY2022Q3	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	1664952	usd
	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-17910210	usd
	UAVS	Net Loss Attributable To Common Stockholders NetLossAttributableToCommonStockholders	-11533356	usd
CY2023Q3	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	742	usd
CY2022Q3	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-97846	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-43302	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs1 AmortizationOfUnrecognizedPeriodicPensionCosts1	-100487	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	7027	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	372368	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-116757	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	220060	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8027897	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1390430	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17750151	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11652929	usd
CY2023Q3	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-49122	usd
CY2022Q3	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-94694	usd
	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-170277	usd
	UAVS	Accrued Dividends On Series F Preferred Stock AccruedDividendsOnSeriesFPreferredStock	-94694	usd
	UAVS	Deemed Dividends On Series F Preferred Stock DeemedDividendsOnSeriesFPreferredStock	-4910894	usd
CY2023Q3	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-8077019	usd
CY2022Q3	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	1295736	usd
	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-22831322	usd
	UAVS	Total Comprehensive Loss Available To Common Stockholders TotalComprehensiveLossAvailableToCommonStockholders	-11747623	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	41180830	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-49122	usd
CY2023Q3	UAVS	Stock Issued During Period Value Conversion Of Warrants Issued With Promissory Note And Incremental Value Modification StockIssuedDuringPeriodValueConversionOfWarrantsIssuedWithPromissoryNoteAndIncrementalValueModification	190500	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	142845	usd
CY2023Q3	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	-742	usd
CY2023Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-7027	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8020128	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	33437156	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43224475	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3817400	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-170277	usd
	UAVS	Stock Issued During Period Value Conversion Of Warrants Issued With Promissory Note And Incremental Value Modification StockIssuedDuringPeriodValueConversionOfWarrantsIssuedWithPromissoryNoteAndIncrementalValueModification	190500	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1125209	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	43302	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	116757	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17910210	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	33437156	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	83600299	usd
CY2022Q3	UAVS	Stock Issued During Period Value Settlement Of Heldback Shares From Contingent Liability Related To Measure Acquisition StockIssuedDuringPeriodValueSettlementOfHeldbackSharesFromContingentLiabilityRelatedToMeasureAcquisition	2812500	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-94694	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12850	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	556837	usd
CY2022Q3	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	97846	usd
CY2022Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-372368	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1664952	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	88278222	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	76576913	usd
	UAVS	Stock Issued During Period Value Settlement Of Heldback Shares From Contingent Liability Related To Measure Acquisition StockIssuedDuringPeriodValueSettlementOfHeldbackSharesFromContingentLiabilityRelatedToMeasureAcquisition	2812500	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	9920000	usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-94694	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4583341	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3000000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	74350	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3058741	usd
	UAVS	Amortization Of Unrecognized Periodic Pension Costs AmortizationOfUnrecognizedPeriodicPensionCosts	100487	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-220060	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11533356	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11533356	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	88278222	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17910210	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11533356	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1125209	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3058741	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3027644	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2887244	usd
	UAVS	Defined Benefit Plan Obligation And Other DefinedBenefitPlanObligationAndOther	-188653	usd
	UAVS	Defined Benefit Plan Obligation And Other DefinedBenefitPlanObligationAndOther	-148851	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	612712	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1523867	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6486899	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1500000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	79287	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-223208	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	396617	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-660208	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2221569	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-237815	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22579	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	264123	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-281937	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-28133	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-193818	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	250379	usd
	UAVS	Payment Of Acquisitionrelated Liabilities PaymentOfAcquisitionrelatedLiabilities	6610900	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-169352	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-307610	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	212606	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	433357	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8829669	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15168736	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95004	usd
	UAVS	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	297596	usd
	UAVS	Capitalization Of Platform Development Costs CapitalizationOfPlatformDevelopmentCosts	635568	usd
	us-gaap	Payments For Software PaymentsForSoftware	171516	usd
	us-gaap	Payments For Software PaymentsForSoftware	565894	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-564116	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8062741	usd
	UAVS	Sales Of Common Stock Net Of Issuance Cost1 SalesOfCommonStockNetOfIssuanceCost1	3817400	usd
	UAVS	Sales Of Common Stock Net Of Issuance Cost1 SalesOfCommonStockNetOfIssuanceCost1	4583341	usd
	UAVS	Sale Of Preferred Stock Series F Net Of Issuance Costs SaleOfPreferredStockSeriesFNetOfIssuanceCosts	3000000	usd
	UAVS	Sale Of Preferred Stock Series F Net Of Issuance Costs SaleOfPreferredStockSeriesFNetOfIssuanceCosts	9920000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	74350	usd
	UAVS	Repayments On Covid Loans RepaymentsOnCovidLoans	87052	usd
	UAVS	Repayments On Covid Loans RepaymentsOnCovidLoans	173313	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6730348	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14404378	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-86257	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-460980	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2749694	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9288079	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4349837	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14590566	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1600143	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5302487	usd
	UAVS	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	7305	usd
	UAVS	Conversion Of Preferred Stock Series F To Common Stock ConversionOfPreferredStockSeriesFToCommonStock	5950	usd
	UAVS	Issuance Of Restricted Common Stock IssuanceOfRestrictedCommonStock	388	usd
	UAVS	Issuance Of Restricted Common Stock IssuanceOfRestrictedCommonStock	316	usd
	UAVS	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	170277	usd
	UAVS	Dividends On Preferred Stock Series F DividendsOnPreferredStockSeriesF	94694	usd
	UAVS	Deemed Dividend On Series F Preferred Stock And Warrant DeemedDividendOnSeriesFPreferredStockAndWarrant	4910894	usd
	UAVS	Stock Consideration For Sensefly Acquisition StockConsiderationForSenseflyAcquisition	3000000	usd
	UAVS	Settlement Of Common Stock From Contingent Liability Related To Measure SettlementOfCommonStockFromContingentLiabilityRelatedToMeasure	2812500	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17910210	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8829669	usd
CY2023Q3	UAVS	Working Capital WorkingCapital	2818220	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-134374548	usd
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	250000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zKyz4TyE8V0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zerRkRsMdiVj">Use of Estimates</span> </i>– The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the reserve for obsolete inventory, valuation of stock issued for services and stock options, valuation of intangible assets, valuation of goodwill, and the valuation of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGEAGLE AERIAL SYSTEMS INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2 – Summary of Significant Accounting Policies-Continued</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	329536	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	496390	usd
CY2023Q3	UAVS	Capitalized Software Development Costs For Internaluse Software CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware	640448	usd
CY2022Q4	UAVS	Capitalized Software Development Costs For Internaluse Software CapitalizedSoftwareDevelopmentCostsForInternaluseSoftware	721795	usd
CY2023Q3	us-gaap	Goodwill Goodwill	21679411	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1500000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	41687871	usd
CY2023Q3	us-gaap	Goodwill Goodwill	21700000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9242659	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11507653	usd
CY2023Q3	UAVS	Shipping Costs ShippingCosts	68966	usd
CY2022Q3	UAVS	Shipping Costs ShippingCosts	75074	usd
	UAVS	Shipping Costs ShippingCosts	191447	usd
	UAVS	Shipping Costs ShippingCosts	220049	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	44701	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	139480	usd
	us-gaap	Advertising Expense AdvertisingExpense	113119	usd
	us-gaap	Advertising Expense AdvertisingExpense	303862	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	138250	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	262737	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	26397	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	79331	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1595576	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1494896	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	997612	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	703741	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2110725	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	2229840	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	95680	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16800	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2015045	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2213040	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	597964	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	791155	usd
CY2023Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1650609	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1680706	usd
CY2021Q4	UAVS	Good Faith Acquisition Ofconsideration GoodFaithAcquisitionOfconsideration	15000000	usd
	UAVS	Covid Loan Disclosuretext Block CovidLoanDisclosuretextBlock	<p id="xdx_80E_ecustom--CovidLoanDisclosuretextBlock_zsvA7GqbYgt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5 – <span id="xdx_828_zFVdUaxu8oT9">COVID Loans</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the senseFly Acquisition, the Company assumed the obligations for two COVID Loans originally made by the SBA to senseFly S.A. on July 27, 2020 (“senseFly COVID Loans”). As of senseFly Acquisition Date, the fair value of the COVID Loan was $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities_iI_c20230930__us-gaap--BusinessAcquisitionAxis__custom--SenseflyMember_zgn2zyV25n01" title="Fair value of the covid loan">1,440,046</span> (“senseFly COVID Loans”). For the three and nine months ended September 30, 2023, senseFly S.A. made the required payments on the senseFly COVID Loans, including principal and accrued interest, aggregating approximately $<span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20220701__20220930__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_ziOVxCNL9FK2" title="Payment of principal and interest"><span id="xdx_904_eus-gaap--RepaymentsOfDebt_c20220101__20220930__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zQ5klFrsWaRg" title="Payment of principal and interest">87,052</span></span> for the three and nine months ended September 30, 2022, respectively, <span id="xdx_90E_eus-gaap--RepaymentsOfDebt_do_c20230701__20230930__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_zehZ0WnydeQ7" title="Payment of principal and interest"><span id="xdx_909_eus-gaap--RepaymentsOfDebt_do_c20230101__20230930__us-gaap--DebtInstrumentAxis__custom--SenseflyMember_z8X2oVCC2Pj5" title="Payment of principal and interest">no</span></span> payments of principal and interest were required. As of September 30, 2023, the Company’s outstanding obligations under the senseFly COVID Loans are $<span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230930__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zxj4qBhtOjQ6" title="Outstanding obligations under the covid loans">815,906</span>. On August 25, 2023, the Company modified one (1) its existing agreements to extend the repayment period of the COVID Loan from a maturity date of December 2023 to June 2025. The other COVID loan remains unchanged.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_898_eus-gaap--ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_zrhkJxlREM5d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, scheduled principal payments due under the senseFly COVID Loans are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zc7gJW2vowb9" style="display: none">Schedule of Maturity of SenseFly Covid Loans</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="text-align: center; font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td id="xdx_49C_20230930__us-gaap--DebtInstrumentAxis__custom--SenseflyCovidLoansMember_zwy7z5Px05D3" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Year ending December 31,</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 77%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023 (rest of year)</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">58,487</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_405_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">306,722</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2025</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,064</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2026</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">90,213</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_406_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">2027</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,420</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--LongTermDebt_iI_pp0p0" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">815,906</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_z5FuGeF1D2v7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4334765	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5288206	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	714596	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1106056	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1412710	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	614400	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	6462071	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	7008662	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	398136	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	322815	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	6063935	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6685847	usd
CY2023Q3	us-gaap	Supplies Supplies	171017	usd
CY2022Q4	us-gaap	Supplies Supplies	281484	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	244628	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	184429	usd
CY2023Q3	us-gaap	Prepaid Rent PrepaidRent	98751	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	234691	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	199046	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	167794	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	41030	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	99558	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	77716	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	61592	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	832188	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1029548	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	774916	usd
CY2023Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	279394	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	288807	usd
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	342873	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	172596	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	236172	usd
CY2023Q3	us-gaap	Depreciation Depreciation	93614	usd
CY2022Q3	us-gaap	Depreciation Depreciation	110176	usd
	us-gaap	Depreciation Depreciation	293538	usd
	us-gaap	Depreciation Depreciation	337826	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11507653	usd
	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	469112	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2734106	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9242659	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P4Y25D
CY2023Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	919774	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	932880	usd
CY2022Q3	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2734106	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2549418	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	811877	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2849173	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1620131	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1221036	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1158057	usd
CY2023Q3	UAVS	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	1582385	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9242659	usd
CY2023Q3	UAVS	Accrued Purchases And Customer Deposits AccruedPurchasesAndCustomerDeposits	220784	usd
CY2022Q4	UAVS	Accrued Purchases And Customer Deposits AccruedPurchasesAndCustomerDeposits	102319	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	406739	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3500000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5000000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.44
CY2022Q4	UAVS	Debt Instrument Original Issue Discount Percent DebtInstrumentOriginalIssueDiscountPercent	0.04	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2022Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3285000	usd
CY2022Q4	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	140000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	75000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1847200	usd
	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	1182349	usd
	UAVS	Debt Instrument Discount Including Fair Value Of Warrants DebtInstrumentDiscountIncludingFairValueOfWarrants	1397350	usd
CY2023Q2	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	175000	usd
CY2022Q2	us-gaap	Investments In And Advances To Affiliates At Fair Value Gross Additions InvestmentsInAndAdvancesToAffiliatesAtFairValueGrossAdditions	3300000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	525000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	175000	usd
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	595000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1523867	usd
CY2023Q3	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	4095000	usd
	UAVS	Gains Losses On Extinguishment Of Debt Net GainsLossesOnExtinguishmentOfDebtNet	2571133	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3500000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	928867	usd
CY2023Q4	UAVS	Net Proceeds Percentage NetProceedsPercentage	0.50	pure
CY2023Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	2000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	84443	usd
	us-gaap	Interest Expense InterestExpense	412188	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	75950	usd
	us-gaap	Interest Expense InterestExpense	236172	usd
	us-gaap	Interest Expense InterestExpense	236172	usd
CY2023Q3	UAVS	Percentage Of Aggregate Of The Offered Securities PercentageOfAggregateOfTheOfferedSecurities	0.50	pure
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	UAVS	Description Of Down Round Or Anti Dilution Trigger Event DescriptionOfDownRoundOrAntiDilutionTriggerEvent	a down round or anti-dilution trigger event occurred resulting in the conversion rate on the Series F and the exercise price of the Series F Warrants issued with the Series F adjusting down to $0.44 from $0.62 and $0.96, respectively (the “December Down Round Trigger”).
	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	2245377	usd
CY2023Q1	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	255976	usd
CY2023Q2	UAVS	Aggregate Deemed Dividend AggregateDeemedDividend	4654918	usd
CY2023Q3	us-gaap	Dividends Dividends	49122	usd
	us-gaap	Dividends Dividends	170277	usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	142845	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1125209	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	556837	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3058741	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	710769	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	538198	usd
CY2023Q3	UAVS	Lieu Payment LieuPayment	15000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2561231	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.18
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	31124	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	325000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.15
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	108499	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.46
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.47
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2777732	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.88
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.02
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y10M2D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6194	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2297691	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.18
CY2023Q3	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue	1.18
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M10D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6194	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2541667	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.88
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.57
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1244029	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	395000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.76
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.36
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted	P3Y7D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	185000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.40
	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	0.29
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10750	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	267294	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	6.22
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.34
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2484373	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.37
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.29
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M19D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	89334	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1836095	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.42
CY2022Q3	UAVS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageFairValue	1.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M28D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	89334	usd
CY2023Q3	us-gaap	Share Price SharePrice	0.32
CY2022Q3	us-gaap	Share Price SharePrice	0.46
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6364	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6984	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0422	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0325	pure
	UAVS	Operating Leases Rent Expense Sublease Rentals OperatingLeasesRentExpenseSubleaseRentals	433137	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	79287	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	24284	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	267745	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	791558	usd
CY2022Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	326542	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1254893	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3498051	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3952317	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	840535	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	628113	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2756056	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3161703	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	312009	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1032155	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1038228	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	816405	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	730781	usd
CY2023Q3	UAVS	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	182695	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4112273	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	515682	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3596591	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	840535	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2756056	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y1M6D
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y9M18D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2023Q3	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	262445	usd
CY2022Q3	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	326542	usd
	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	790783	usd
	UAVS	Cash Paid For Amounts Included In Measurement Of Liabilities Operating Cash Flows For Operating Leases CashPaidForAmountsIncludedInMeasurementOfLiabilitiesOperatingCashFlowsForOperatingLeases	1245893	usd
CY2023Q1	us-gaap	Additional Liability Long Duration Insurance Gross Premium Income AdditionalLiabilityLongDurationInsuranceGrossPremiumIncome	3000000	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	2126081	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	3155867	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	190000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	21679411	usd
CY2023Q3	us-gaap	Assets Assets	46050487	usd
CY2022Q4	us-gaap	Goodwill Goodwill	23179411	usd
CY2022Q4	us-gaap	Assets Assets	54184874	usd
CY2023Q3	us-gaap	Revenues Revenues	3483932	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	2269858	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5990113	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2030015	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-8020128	usd
CY2022Q3	us-gaap	Revenues Revenues	5490714	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3407573	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5147330	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6812282	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	1664952	usd
	us-gaap	Revenues Revenues	10819213	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6594973	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15023060	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2887150	usd
	us-gaap	Net Income Loss NetIncomeLoss	-17910210	usd
	us-gaap	Revenues Revenues	14620565	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8622436	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18017851	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6484495	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11533356	usd
CY2023Q3	us-gaap	Revenues Revenues	3483932	usd
CY2022Q3	us-gaap	Revenues Revenues	5490714	usd
	us-gaap	Revenues Revenues	10819213	usd
	us-gaap	Revenues Revenues	14620565	usd

Files In Submission

Name	View Source	Status
uavs-20230930_cal.xml	Edgar Link	unprocessable
0001493152-23-040239-index-headers.html	Edgar Link	pending
0001493152-23-040239-index.html	Edgar Link	pending
0001493152-23-040239.txt	Edgar Link	pending
0001493152-23-040239-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uavs-20230930.xsd	Edgar Link	pending
uavs-20230930_def.xml	Edgar Link	unprocessable
uavs-20230930_lab.xml	Edgar Link	unprocessable
uavs-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs

2023 Q4 Form 10-Q Financial Statement

#000149315223040239 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS AgEagle Aerial Systems Inc. Stock $uavs

2023 Q4 Form 10-Q Financial Statement

#000149315223040239 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAVS
AgEagle Aerial Systems Inc. Stock $uavs